Immunology Market Set To Grow Owing To Rising Prevalence Of Cancer And Autoimmune Diseases
The global immunology market involves developing and providing monoclonal antibodies, cytokines, stem cell therapies, and other immunotherapeutic drugs for treating various diseases. Immunotherapies enhance the body's natural defenses to fight cancer, autoimmune disorders, and infectious diseases. Monoclonal antibodies are predominantly used immunotherapies that can selectively target specific cancer cells and proteins. The market also includes stem cell therapies that help restore the body's normal functions and relieve symptoms of disorders.
The global immunology Market is estimated to be valued at US$ 107,133.84 Mn in 2023 and is expected to exhibit a CAGR of 17% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
The global immunology market is witnessing high growth owing to the rising prevalence of cancer and autoimmune diseases globally. According to various studies, cancer accounted for nearly 10 million deaths in 2020 and is one of the leading causes of mortality worldwide. Similarly, autoimmune diseases like rheumatoid arthritis, multiple sclerosis, and lupus are also on the rise. The development of innovative monoclonal antibodies and immunomodulating drugs to treat these diseases is a key factor fueling market growth. Furthermore, increasing healthcare expenditure and demand for superior treatment options have led manufacturers to invest heavily in R&D of advanced immunotherapies. Although high development costs of immunotherapies remain a challenge, favorable government initiatives and reimbursement schemes are creating new opportunities in the market.
SWOT Analysis
Strength: The Immunology Market Share is expected to exhibit strong growth over the forecast period. Growing prevalence of various autoimmune and immunological disorders globally is driving the demand for immunology products. Rising awareness regarding immunological treatments and therapies is further supporting the market growth. Continuous development of novel and advanced treatment options by key players is also strengthening their product portfolios.
Weakness: High costs associated with R&D activities in immunology relates to developing novel treatment approaches hampers the market growth. Also, stringent regulations for approval of new immunological drugs and therapies poses challenges for market players.
Opportunity: Growing healthcare expenditures in emerging economies provides lucrative opportunities for major market players to expand their regional presence. In addition, rising focus on development of biosimilars provides new opportunities over the coming years. Also, ongoing clinical trials evaluating new drug candidates will further support market revenues if successful.
Threats: Presence of alternative treatment therapies and emergence of generic versions once patents expire poses threats to market players. Uncertainty in regulatory approval and reimbursement scenarios across various regions also poses challenges.
Key Takeaways
The global immunology market is expected to witness high growth over the forecast period. The global immunology Market is estimated to be valued at US$ 107,133.84 Mn in 2023 and is expected to exhibit a CAGR of 17% over the forecast period 2023 to 2030.
North America is currently the dominant as well as the fastest growing regional market for immunologies. Rising prevalence of immune disorders, presence of advanced healthcare facilities, and increasing healthcare expenditures are some factors supporting market growth in the region. The U.S. holds majority market share owing to high adoption of novel immunological therapies. Europe also captures significant revenue share in the global market supported by growing research activities for drug development. However, Asia Pacific region is projected to exhibit highest growth during the forecast period owing to rising healthcare awareness, increasing patient population, and improving healthcare infrastructure across countries. Emerging economies like India, China, and South Korea are projected to attract major market players looking to expand their regional presence.
Key players operating in the immunology market are Production I.G, Inc., Studio Ghibli, Inc., Pierrot Co., Ltd., Sunrise Inc., Toei Animation Co., Ltd., BONES INC, Kyoto Animation Co.,Ltd., MADHOUSE Inc., Manglobe Inc., and PAWORKS Co., Ltd.. These companies focus on new product launches, collaborations, and geographic expansions to strengthen their market positions.
For more insights, read- https://www.pressreleasebulletin.com/immunology-market-trends-size-and-share-analysis/
For more details on the report, Read- https://www.newsstatix.com/luxury-travel-market-trends-size-and-share-analysis/
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian